Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT02963831What this trial is testingInvestigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal MalignanciesWho this might be right forColorectal CancerOvarian CancerAppendiceal Cancer Ludwig Institute for Cancer Research 67
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Looking for participantsNCT04779554What this trial is testingFlat Dose vs. Weight-based IP Chemotherapy for CRS/HIPECWho this might be right forPeritoneal Carcinomatosis Prakash Pandalai 100
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Early research (Phase 1)Study completedNCT00003046What this trial is testingInterleukin-12 in Treating Patients With Cancer in the AbdomenWho this might be right forAnal CancerColorectal CancerGallbladder Cancer+2 more M.D. Anderson Cancer Center 29
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT03108131What this trial is testingCobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare TumorsWho this might be right forSkin Squamous Cell CarcinomaAppendix AdenocarcinomaRare Lesion+9 more M.D. Anderson Cancer Center 49
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05462717What this trial is testingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more Revolution Medicines, Inc. 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT05194995What this trial is testingJAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C MutationWho this might be right forAdvanced Colorectal CancerSmall Intestinal CancerAppendiceal Cancer Allist Pharmaceuticals, Inc. 48